Enterprise Value
89.6M
Cash
12.04M
Avg Qtr Burn
-5.105M
Short % of Float
1.61%
Insider Ownership
0.65%
Institutional Own.
25.11%
Qtr Updated
03/31/24
Drug Pipeline
Powered by
![](/BPIQ_Pill.png)
Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.
Drug & Indication | Stage & Event | Catalyst Date |
---|---|---|
LTI-01 Details Loculated pleural effusions | Phase 2b Initiation | |
LTI-03 Details Idiopathic pulmonary fibrosis | Phase 1b Data readout | |
ALRN-6924 Details Cancer, Breast cancer | Failed Discontinued | |
ALRN-6924 Details Cancer, Non-small cell lung carcinoma | Failed Discontinued | |
ALRN-6924 Details Cancer, Small cell lung cancer, Solid tumor/s | Failed Discontinued |